Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Michael Allen Jerman is Director at Alaunos Therapeutics. OQRO lists 5 transactions filed with the SEC under this name, the latest on Oct 8, 2026, each linked to the official Form 4.
Director
Disclosures on record
5
Companies involved
1
Alaunos TherapeuticsTCRT
5 disclosures · Nov 2025 – Oct 2026
Oct 6, 202621Kdisclosed Oct 8
DetailsOfficial recordJul 23, 20268,138disclosed Jul 27
DetailsOfficial recordApr 29, 20266,032disclosed May 1
DetailsOfficial recordJan 12, 20265,406disclosed Jan 15
DetailsOfficial recordNov 21, 20254,183disclosed Nov 27
DetailsOfficial recordAs of the latest filing on , Michael Allen Jerman reported holding 44,749 shares of Alaunos Therapeutics (TCRT), worth about $71K at the last close of $2 (Nov 19, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Alaunos Therapeutics TCRT | 44,749 | 45K direct | $2 | $71K | Oct 6, 2026 |
Is this Michael Allen Jerman’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
On the latest SEC Form 4, dated Oct 6, 2026, Michael Allen Jerman reported holding 44,749 shares of Alaunos Therapeutics (TCRT). At the last close of $2 on Nov 19, 2026, that is about $71K. This is the stake disclosed in filings, not a net worth.
No public filing gives Michael Allen Jerman's net worth. What SEC Form 4 shows is the stock stake: 44,749 shares of Alaunos Therapeutics (TCRT), about $71K at the last close. Cash, other investments, property, debts and unexercised options are not in these filings, so the real figure can be much higher or lower.